How Schools and Students Can Help

One of life's most valuable lessons - best learned at a young age - is that we're all made better when we help others. The Leukemia & Lymphoma Society's School & Youth Programs offer children hands-on experiences that cultivate caring, respect and sharing with others.


The No. 1 reason for your school to get involved is that School & Youth Programs let children experience the powerful feeling that comes from achieving a goal that benefits others. The Leukemia & Lymphoma Society provides curriculum guides to help teach children about leukemia and why it is so important to fund cures.


Since 1993, millions of dollars have been raised in pennies and other spare change by more than 10 million pre-school, elementary, middle and high school students throughout the country. The funds, collected during a three-week period, benefit the Society's mission.


Participating classrooms raise funds in honor of someone in their area who has been diagnosed with a blood cancer. Sometimes it is someone who attends their school. As children bring in their spare change from under the couch, jars and shoe boxes, they learn the importance of raising money to help save lives.


Call (800) 955-4572 for more information or visit http://www.schoolandyouth.org

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap